Another setback is that the AAV8-1.3HBV vector given i.v. to mice, unlike a natural infection in humans, fails to induce detectable CD8+ T cell responses to antigens of HBV so that the vaccine may primarily have activated naive rather than memory T cells, as would be expected upon vaccination of patients with CHB. Here, CD8A is linked to infection.